Cédric Boularan

Title: Cédric Boularan: Innovator in Immunomodulatory Compounds

Introduction

Cédric Boularan is a notable inventor based in Toulouse, France. He has made significant contributions to the field of immunology through his innovative research and patents. His work focuses on developing compounds that can enhance immune responses, particularly in the context of treating diseases.

Latest Patents

Cédric Boularan holds a patent for "Pro-cyclic dinucleotides and pro-cyclic dinucleotide conjugates for cytokine induction." This invention provides a Pro-cyclic dinucleotide (Pro-CDN) that includes a STING agonist cyclic dinucleotide coupled to a linker system. The Pro-CDNs can be metabolized at targeted sites into CDNs, allowing them to exert their full immunomodulatory effects. The invention also encompasses conjugates where a Pro-CDN is linked to a Biologically Active Molecule (BAM), such as cytotoxic molecules, lipids, proteins, peptides, nucleic acids, sugars, or PRR ligands. Furthermore, the patent outlines methods for using these compounds to achieve cytotoxic, cytostatic, or immunomodulatory effects, aiming to treat or prevent diseases like cancers, immunological disorders, or infections.

Career Highlights

Cédric Boularan is associated with Invivogen, a company that specializes in developing innovative solutions for immunology and molecular biology. His work at Invivogen has been instrumental in advancing the understanding and application of immunomodulatory compounds.

Collaborations

Cédric has collaborated with notable colleagues, including Michèle Tiraby and Thierry Lioux, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Cédric Boularan's contributions to the field of immunology through his patent on Pro-cyclic dinucleotides highlight his role as an influential inventor. His work continues to pave the way for new therapeutic approaches in treating various diseases.